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The microanatomy of T-cell
responses
Summary: The priming of a T cell results from its physical interaction
with a dendritic cell (DC) that presents the cognate antigenic peptide. The
success rate of such interactions is extremely low, because the precursor
frequency of a naive T cell recognizing a specific antigen is in the range of
1:105–106. To make this principle practicable, encounter frequencies
between DCs and T cells are maximized within lymph nodes (LNs) that
are compact immunological projections of the peripheral tissue they drain.
But LNs are more than passive meeting places for DCs that immigrated
from the tissue and lymphocytes that recirculated via the blood. The
microanatomy of the LN stroma actively organizes the cellular encounters
by providing preformed migration tracks that create dynamic but highly
ordered movement patterns. LN architecture further acts as a sophisticated
filtration system that sieves the incoming interstitial fluid at different levels
and guarantees that immunologically relevant antigens are loaded on DCs
or B cells while inert substances are channeled back into the blood
circulation. This review focuses on the non-hematopoietic infrastructure
of the lymph node. We describe the association between fibroblastic
reticular cell, conduit, DC, and T cell as the essential functional unit of the
T-cell cortex.
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Adaptive immunity depends on secondary
lymphatic tissues
Innate immune cells are constantly patrolling the body. Within
minutes of local infection, they are recruited to the site of
damage where they exert their defense function. The speed of
such responses is possible because the innate immune cells are
always available: some are resident within the tissue and some
are quickly recruited from the bloodstream, where they are
either freely circulating or patrolling along the endothelial
lumen (1–4). As there are only few types of specialized innate
immune cells, the copy number of each type is high, and
supply is always guarantied. Adaptive immune responses are
fundamentally different, because the number of specialized cell
types is in the range of many millions, as lymphocytes of
different specificity are randomly generated during somatic
development. Naturally, the copy numbers of each specific cell
type are extremely low. It was recently demonstrated that for an
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a few hundreds (5, 6). Hence, the few specialized cells that
recognize an antigen have to be expanded before they can
effectively invade any tissue. The principle of lymphocyte
activation/expansion is based on stochastic encounters be-
tween the antigen-presenting cells of the innate immune
system, the dendritic cells (DCs), and T cells. Once the T cell
physically contacts the DC presenting its cognate antigen, it is
activated and expanded to a population size that is now
sufficient to effectively invade the infected sites.
Secondary lymphatic organs are the solutions to solve the
‘needle in the haystack’ problem of identifying and expanding
rare T cells within reasonable time frames. The prototypic
example of a secondary lymphatic organ is the lymph node
(LN), which we discuss in this review. LNs are compact
immunological projections of the patch of peripheral tissue
that they drain. DCs that collected information and antigens in
the periphery migrate via the afferent lymphatic vessels into the
draining LN. Once in the T-cell area, the immigrated DCs
display, based on the information they received in the
periphery, the antigen in a context that instructs the T cell to
differentiate into the adequate effecter type (7). T cells
recirculate through the LNs with the bloodstream that
they leave via high endothelial venules (8). Within the
T zone, the necessary high encounter rates between DCs and T
cells are maintained by rapid cell locomotion that is effectively
organized by chemokines (9). The big advantage of this
system is that instead of scanning the whole periphery,
naive T cells just visit the LN and receive all the instructions
they need. Indeed, the adaptive immune system is so
highly dependent on its organization centers that in the
absence of secondary lymphatic organs, adaptive immunity is
abolished (10).
Upon closer inspection, the schematic concept of
immigrating DCs being the representation of the periphery is
too simplified, and the reality is more complex. LNs are not
only receiving DCs with the afferent lymph but also the whole
stream of interstitial fluid with all its contents: soluble antigens,
intact microbes, microbial particles, and locally produced
extracellular signaling molecules like cytokines and
chemokines. LNs are fluid filters that are providing the
infrastructure to collect, select, and load soluble antigens on
DCs that are permanently residing in the T zone. The filter
function also physically prevents that replicable pathogens
spread systemically via the blood circulation. LNs are also
‘information hubs’ that are quickly relaying soluble signals
from the periphery toward the T cells in the blood circulation.
Finally, it seems likely that LNs are critical regulators of the
fluid balance between interstitium and blood.
The anatomy of LNs is complex, extremely dynamic, and
until 2001, it was largely ignored by immunologists. Only the
rise of intravital imaging technologies within the last years
brought structural aspects of the lymphatic system back into
the mind of the immunologist. Numerous excellent reviews
are available that summarize the emerging knowledge of
leukocyte motility patterns within LNs (11–13). However, the
focus was largely on the hematopoietic fraction of the LN that
is relatively easy to visualize. The mesenchymal infrastructure
of the LN that supports and directs the blood cells is still poorly
appreciated. Closely connected to the mesenchymal anatomy is
the question of fluid dynamics within the lymphatic system.
Although a detailed physiological knowledge of particle and
solute transport will be necessary to understand the kinetics of
infections at the organismic level, many aspects of these
processes are not investigated.
In this review, we describe the non-hematopoietic
infrastructure of the lymphatic system in the functional
context of cell migration and fluid drainage. Our focus is the
T-cell response, as the B-cell compartment has been reviewed
recently (14), but we mention the B cells when necessary for
comparative purposes. We use the skin and the draining LN as
an example. For two reasons we also include an overview over
the dermal microenvironment. First, almost every immune
response is initiated in the periphery, and the dermal fluid and
cell drainage system is critically involved in the initiation of
adaptive immunity. Second, molecular composition and
physiological characteristics of the dermal interstitium are
well investigated and serve as a model to further discuss
LN physiology that follows the same principles but is still an
open field.
Circulation patterns of fluids
While cells and some microbes have the possibility to move
autonomously, extracellular substances within vertebrates are
either immobilized to cells or molecular components of the
extracellular matrix (ECM) or they move with the bulk flow of
fluid by convective forces, meaning that they are flushed (15).
The interstitial fluid of vertebrates appears in several different
forms while it is recirculating through the body. The plasma
fraction of the blood is the most accessible variant. In the
capillary bed, plasma is filtrated from the vasculature and
becomes interstitial fluid, which is slowly percolating through
the interstitium into the afferent lymphatic vessels (16). From
there on it is termed afferent lymph. The afferent lymph is
filtered through the draining LN, and once it has exited the LN
is termed efferent lymph. In larger vertebrates and humans
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(but not in mice), the efferent lymph is filtered through a
hierarchy of second- and third-order LNs before it enters the
cisterna chyli and is further actively transported via the thoracic
duct back into the venous blood circulation (17, 18). All
particles will passively follow the convective drag of the
interstitial fluid if they are not immobilized or taken up by
cells, trapped by binding to ECM, or filtered at a barrier due to
size reasons. As a consequence of the different filtration steps,
plasma, interstitial fluid, afferent lymph, and efferent lymph
have quantitatively different molecular compositions, although
they are in continuous exchange (19) (Fig. 1).
The peripheral tissues: dermis
After breaking the barrier of the epidermis, extracellular
pathogens either spread laterally, grow into deeper areas, or
distribute systemically by accessing the blood vasculature. The
molecular architecture and the hydrostatic conditions within
the dermis dictate that the fluid and particle stream is strictly
directed from the blood vessel into the lymph vessel (16, 19).
This convective stream counteracts entry into the blood circu-
lation by flushing particles away from blood vessels. Further-
more, the small pore size of the interstitium acts as a sterical
barrier for active spreading. We start by describing general
features of the dermal compartment, with focus on the
questions of how molecular anatomy determines the transport
of solutes, particles, and immune cells. The dermal stroma
consists of two components: the stroma cell (typically a
fibroblast) and the ECM that the stroma cell produces. The
dermis is characterized by a wide extracellular space that is
scaffolded by dense arrays of biopolymers. The fibroblasts are
scattered within the tissue without forming cell–cell contacts.
They are rather embedded as single cells into the surrounding
ECM. Owing to the spacing, fibroblasts themselves do not form
any significant barrier for solutes, cells, or particles (20). The
ECM can be functionally divided into two categories: the
fibrillar fraction that consists of arrays of fibrillar collagen
bundles, elastic fibers, and microfibrils, and the non-fibrillar
fraction that consists mainly of long-chained aminosugars
(glycosaminoglycans) and proteoglycans. The fibrillar fraction
is mechanically stable and counteracts the tension produced by
the fibroblasts that contract the extracellular fibers via acto-
myosin forces (21). The interplay between fibroblasts and
fibers determines the mechanical characteristics of the skin.
The non-fibrillar fraction fills the volume between the fibers.
Unlike the fibrillar proteins, these extremely large sugars
(chains of hyaluronic acid can reach a length up to 5 mm and a
molecular weight of several million Daltons) are not tightly
interconnected, and biophysically they rather behave like a very
viscous fluid (22). Glycosaminoglycans are highly negatively
charged and therefore bind ions and, as a consequence, attract
and immobilize water. By sucking water, they act as ‘expansion
elements’ that counteract the tensile force of the fibrillar ECM
fraction (16).
Solute transport within the dermis
What are the driving forces of interstitial flow? The flow is a
function of Starling’s forces that set the capillary filtration rate:
the local hydraulic pressure difference (blood pressure–inter-
stitial pressure) across the blood vessel wall minus the colloid
osmotic pressure difference between blood and interstitium
(23). The hydraulic pressure of the dermal interstitium is
actively kept low by the suction force of the lymphatic vessels
































Fig. 1. Circulation patterns of fluids. Small particles (small dots)
become filtrated from the blood stream (red) in the periphery, enter the
afferent lymphatic vessel (yellow), and are transported into the draining
LN. Here, they are directly reabsorbed into the bloodstream. Large
particles (large, open dots) also enter the afferent lymphatic vessel but
percolate through the sinus system of the LN and eventually (if they are
not trapped in the sinus) are channeled via the efferent lymphatic vessel
and the thoracic duct back into the blood circulation.
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Under normal conditions the interstitial flow is slow, because
the hydraulic conductivity of the interstitium is low. Conduc-
tivity is set by the pore size (the hydraulic radius) of the
interstitium that is determined by the surface area of glycosa-
minoglycans and fibrillar ECM that is filling the interstitium. In
the dermis, this radius is in the range of 100 nm, so that the
interstitium is a sterical barrier for bigger particles like viruses
or bacteria (24). The low mobility of interstitial water that is
caused by the charged glycosaminoglycans prevents quick
shifts of interstitial fluid upon pressure changes and restricts
the diffusive or convective distribution of soluble molecules,
even under mechanical stress. Only in the situation of periph-
eral lymphedema is the glycosaminoglycan fraction saturated
with water. This dilution leads to the effect that the excess
water moves freely (16, 25, 26). Therefore, edematous tissue
can be easily ‘squeezed out,’ which is used as a simple clinical
test: pushing into edematous skin but not into healthy skin
leaves a pit. To our knowledge, the consequences of edema for
particle transport have not been investigated systematically, but
it is a clinical fact that peripheral edema predisposes for local
infection (27) (Fig. 2).
There are two important implications for particle and solute
transport within the dermis. (i) In principle, solutes and small
molecules can freely diffuse, but their transport is dominated
by the convection caused by the bulk fluid movement that is
directed from the capillaries into the lymphatic vessels. The
dermis is in a state of constant fluid secretion, and although this
is frequently stated, re-absorption of fluid and solutes in the
efferent capillary bed or across venules does not occur
normally. (ii) For larger particles, the pore size of the
interstitium is a sterical barrier. They ‘become filtered,’ and
the only way to spread is by autonomous movement, digestion
of the ECM, and subsequent increase of the pore size, or by
‘hitchhiking’ with cells.
Cell migration within the dermis
A soluble molecule or a particle can reach the draining LN via
two principal routes: passively with the interstitial flow or
carried by cells. The usual cell type that carries antigens into the
LN is the DC. In the steady state, DCs are forming an area-wide
network that constantly samples the tissue for internal (da-
mage) or external (microbes) danger signals (7). Within the
skin, there are two populations of resident DCs: the Langerhans
cells of the epidermis that reside between the keratinocytes
above the epidermal basement membrane (28, 29) and the
dermal DCs that are scattered within the interstitium (30).
Upon danger sensing, DCs undergo so-called maturation. DCs
transiently become phagocytotic and subsequently acquire
a state of high motility (7, 31). This metamorphosis from
a rather static cell that adheres to the ECM via integrins to a very
motile cell is associated with the upregulation of the chemo-
kine receptor 7 (CCR7) that guides the cells toward the afferent
lymphatics that are expressing the CCR7 ligand CCL21 (31).
How do DCs migrate through the interstitial microenviron-
ment? Considering the textbook paradigm that cell migration
in metazoans relies on integrin-mediated coupling of cytoske-
letal force to the ECM (32), it seems rather paradoxical
that we and others found that upon maturation, DCs function-
ally inactivate their integrins (28, 29). However, we recently
learned that DC migration in the interstitium is completely
integrin independent. We rather found that DCs move through
the fibrillar scaffold of the interstitium by a protrusive flowing
of the actin cytoskeleton and by occasional contractions of the
trailing edge that facilitates squeezing of the non-elastic
nucleus through narrow areas (T. Lämmermann et al., unpub-
lished observations). Proteolytic digestion of fibrillar matrices
is not required for this very quick mode of movement, and
the spacing of the fibers is obviously large enough for the
cells to squeeze through (33). Hence, leukocyte migration
through the interstitium happens without causing permanent
damage by remodeling or rearrangement of ECM; the cells




Fig. 2. Interstitial flux within the dermis. Plasma becomes filtrated
from the blood vessel (red). The endothelium and the endothelial
basement membrane (brown) form a semi-permeable membrane. The
interstitial flux (arrow) is strictly directed from the blood vessel toward
the lymphatic vessel (yellow) that has no continuous basement mem-
brane but flap valves opening toward the lumen. The interstitial matrix
(blue) consists of collagen fibers (thick lines), microfibrils (thin lines),
and glycosaminoglycans (brush like structures). Fibroblasts (green)
associate with the interstitial matrix.
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unclear how cells handle the tight network of glycosaminogly-
cans that fills the space between the fibers. It is likely that these
polymers are just pushed away. This is possible because the
glycosaminoglycan network is not tightly crosslinked and is
rather fluid.
The basement membrane as a specialized ECM
Although the interstitial matrix is not allowing unrestricted
movement of particles, there is a variant of the ECM of much
lower permeability: the basement membrane. Basement mem-
branes underlie epithelia and endothelia and surround axons,
fat, and muscle cells. Rather than a loose scaffold like the inter-
stitial matrix, basement membranes are dense sheets of tightly
interconnected glycoproteins of the laminin and the non-
fibrillar collagen IV families that are coupled together by bridg-
ing molecules like nidogens (35). Basement membranes do
not only serve mechanical functions but also act as molecular
sieves, anchoring structures and polarity signals for polarized
cells, pathways or barriers for migrating cells, and, importantly,
they harbor heparan sulfate proteoglycans like perlecan and
agrin. These sulfated proteoglycans are again serving as mole-
cular sinks, storage sites, or presentation platforms for the
many heparan sulfate-binding growth factors and chemokines
(36). Basement membranes strongly vary in their molecular
composition, depending on the cell type they are produced by
and associated with. Sixteen different laminin isoforms with
distinct tissue-specific and developmental expression patterns
and distinct cell-binding and biophysical characteristics are
only one example of the highly specialized and not well-
explored specializations of basement membranes (37).
Role of basement membranes for solute transport
The role of basement membranes in fluid filtration is not well
investigated, except in the kidney where the primary urine is
filtered through the basement membrane associated with the
podocyte endfeet. Here, a dual role as a sterical and a charge
filter for molecules above the size of albumin has been
proposed (38). Three basement membranes transect the skin
in a way that they might be relevant for fluid filtration: the
basement membrane of the epidermal–dermal junction, of the
blood vessel endothelium, and of the lymphatic endothelium.
Although no functional studies are available, it appears likely
that the endothelial basement membrane contributes to the
semi-permeability of the blood vessel (39). The same is
possible for the epidermal basement membrane, while the
basement membrane of the lymphatic endothelium appears to
be functionally different. It has long been doubted that lymph
vessels have at all an underlying basement membrane and
lymphatic endothelial cells can be differentiated from blood
endothelial cells by very low expression levels of collagen IV
and laminins (40–42). Only recently it became clear that the
basement membrane of lymph vessels exists but that it is very
fragile and also fragmented (43, 44). This structural config-
uration makes it unlikely that the lymphatic basement mem-
brane is a significant barrier to fluid movement.
The role of basement membranes for cell migration
Basement membranes are structurally dense and as such
require specialized mechanisms if they should be transmi-
grated (45). Leukocytes can circumvent most dermal basement
membranes, and the only sites where transmigration is neces-
sary are the endothelial basement membrane of venules and the
epidermal basement membrane. Cells have to penetrate these
barriers to leave the bloodstream and the epidermis, respec-
tively. Passing the epidermal basement membrane clearly
requires proteolytic degradation and likely also integrin-
mediated adhesion, as demonstrated for epidermal Langerhans
cells and autoreactive T cells (45–48). For extravasating
leukocytes that have traversed the endothelial monolayer and
face the underlying basement membrane, this is less clear.
Recently, it has been suggested that preformed openings (also
called low expression sites as they show low levels of laminins
and collagen IV) allow neutrophils to squeeze through the
membrane without creating defects (49). Passing the rudimen-
tary basement membrane of the lymphatics does not require
active proteolytic mechanisms, and DCs likely enter via pre-
formed openings (our unpublished data).
The lymphatic vessels
Entry of fluid into the lymphatic vessels
The lymphatic vessels actively pump interstitial fluid out of the
tissue and thereby keep the interstitial pressure low and
guarantee that flow is unidirectional away from the capillary
bed. In most tissues, the lymphatic vessels are the only route of
fluid absorption, and efferent capillaries and venules are not
pathways of significant absorption (LNs and the gut are
exceptions as we discuss below) (19). Unlike blood vessels,
lymph vessels openly communicate with the interstitium. No
tight endothelial barrier or continuous basement membrane
restricts the movement of solutes. The suction force of the
lymph vessel is generated by the interplay of four functional
units: (i) the smooth muscle layer around the lymphatic
collector vessels (the proximal part of the lymphatics) periodi-
cally contracts and thereby pushes fluid toward the draining
LN, (ii) backflush of fluid into the periphery during contractile
phases is prevented by the semilunar valves between segments
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of collector vessels, (iii) the lymphatic endothelial cells of the
blind ending initial (distal) part of the lymphatics are arranged
in an overlapping pattern that forms flap valves that allow entry
but prevent exit of fluid, and (iv) the abluminal side of the
lymph vessels are anchored to the interstitial fibrillar matrix via
elastic filaments. Using the tensile force of the interstitial ECM,
these filaments pull the lumen of the lymphatics open, even
when interstitial pressure rises during edema. Edema rather
enforces the opening of the lumen as it raises the tension
within the interstitial matrix (50).
Cellular entry into the lymphatic vessels
How cells enter lymphatic vessels has not been thoroughly
investigated in vivo. Several adhesion molecules have been
implicated in this process based on in vitro assays or pharmaco-
logical inhibition. These molecules include the cell surface
receptor clever 1 (51) and the interaction between leukocyte
function-associated antigen-1 (LFA1) and very late antigen 4
(VLA4) on the DC and its counter ligands vascular cell adhesion
molecule-1 (VCAM-1) and intracellular adhesion molecule-1
(ICAM-1) on the abluminal side of the lymphatic vessels (52).
However, a recent report (and our own data) suggests that like
for fluid transport, for cellular trafficking, the lymphatic vessels
might not be a considerable barrier. The cell–cell contacts
between the lymphatic endothelial cells at the level of initial
lymph vessels are discontinuous. Instead of the continuous
adherens junctions that are found between blood endothelial
cells, the junctions between lymphatic endothelial cells are
organized as ‘buttons’. Within the buttons, the same molecular
connectors, platelet-endothelial cell adhesion molecule-1
(PECAM-1) and VE Cadherin, are found as in the blood vessels.
The spacing between the buttons is in the range of 3 mm (53).
Although not formally demonstrated, the resulting gaps would
be sufficient for DCs and lymphocytes to squeeze through
without using specialized mechanisms of intravasation. Such a
passive model would imply that lymphatic entry is only
determined by the chemokine cue that guides the cells into
the vessel. Lymphatic vessels express high levels of CCL21 (54),
which could result in a diffusive gradient that attracts the
leukocytes into the vessel. However, the mechanism of this
process is far from clear, as the continuous interstitial flux
would counteract a diffusive distribution of chemokine away
from the lymphatic vessel and would instead suck CCL21 into
the vessel. Recently, Swartz and colleagues (55, 56) suggested
an alternative model for chemotactic migration within the
dermis that was termed ‘autologous chemotaxis.’ Many cells
expressing CCR7 also express the ligand CCL19, which seems
paradox at first sight. However, within the interstitium, con-
vection will drag the secreted chemokine toward the lymph
vessel and thereby create a gradient that can then be followed
by the same cell. Autologous chemotaxis was demonstrated for
metastatic tumor cells moving into lymph vessels and also was
suggested as a driving force for DC migration into the
lymphatics (55, 56). Although this concept appears appealing,
it remains to be challenged in vivo by either testing if CCL19-
deficient DCs migrate less or, more importantly, showing that
even in the absence of CCL21 on lymphatic vessels DCs can
move directionally into the lymph vessels.
Transport within the lymphatic vessels
It is beyond doubt that transport within the lymphatic vessels is
the same for solutes and cells. It is a passive flowing with the
stream of interstitial fluid that is powered by the periodic
contractions of the lymphatic vessels. Cells and fluid are
pumped directly into the subcapsular sinus of the node (50).
Within the sinus, the sieving function of the LN starts. In the
following we describe anatomy and physiology of the LN, and
as in the previous section, we separately discuss the implica-
tions for the transport of solutes and the migration of cells.
The LN sinuses
Two anatomically distinct compartments of the LN are distin-
guished: the sinus and the cortex. Both consist of a stromal and
a hematopoietic component. The most simplified view of a LN
is that of an organ bathing within the lumen of a dilated
lymphatic vessel. The sinuses represent the remaining lumen of
the vessel, and the cortex represents the actual organ. Usually
LNs mark sites where lymph vessels coming from different
drainage areas meet, and therefore every LN has several afferent
but most times only one efferent lymph vessel. The entry side
of the LN that is close to the afferent vessels is called
subcapsular sinus, and the one close to the efferent vessel is
called the medullary sinus (57). As the sinus system surrounds
the whole LN, the subcapsular and medullary sinuses are
directly interconnected, and there is an open communication
between them. Hence, cells, fluid, and soluble molecules can
pass through the LN without contacting the cells of the cortex
(58). In larger LNs, there are also intermediate sinuses that
penetrate the parenchyma and constitute a direct route be-
tween afferent and efferent lymph (57, 59, 60). It has further
been described that the deep cortex harbors a lymphatic
labyrinth that is connected to the medullary sinus. These are
blind ending sinuses that likely collect emigrating lymphocytes
and lead them into the medulla (59, 60).
The subcapsular sinus is populated by different resident cell
types. The stromal cell of the sinus is the sinus reticular cell or
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retothelial cell (61–64). This cell type has morphological
similarities with the fibroblastic reticular cell (FRC) of the
T-cell area but is also carrying some typical surface markers of
the lymphatic endothelial cell lineage (65). The retothelial cells
constitute a three dimensional meshwork that is the backbone
of the sinus and bridges the LN capsule with the LN cortex (60,
66). The retothelial cells are assembled around an ECM scaffold
that appears different from the stroma of the periphery and
already shows features of the conduit structures of the T-cell
area. Bundles of fibrillar collagens transect the sinus and
connect the fibrous capsule of the LN with the ECM of the
conduits in the T-cell area (67). These collagen bundles are
partially surrounded by a basement membrane and are
completely enwrapped with stroma cells (59, 68–70). They
form a structure that resembles the conduit of the T-cell stroma.
Unlike in conduits, in the sinus the basement membrane is
discontinuous and rather resembles rings or spirals. At some
places where the basement membrane is more patchy, it takes
the configuration of buttons that are connecting the cells with
the interstitial matrix of the fibers (71). The functional
significance of this ECM assembly has not been investigated. It
appears likely that such a structure facilitates fluid drainage and
at the same time gives structural support. The discontinuous
nature of the basement membrane is also reminiscent of the
button-like cell–cell adhesions of the initial lymphatics, with
the exception that the retothelial cells build a three dimensional
sponge-like structure instead of the two-dimensional sieve
structure of the lymphatics. The interstitial matrix of the sinus is
not qualitatively different from the interstitium of the dermis – it
is just assembled in a more organized and condensed manner.
The same is the case for the retothelial cells that appear like a
condensed form of the dermal mesenchyme. While the dermal
fibroblasts are scattered within the interstitium as single cells, the
retothelial cells assemble a unique and complex type of cell–cell
junctions that have been termed puncta adherentia (62).
The connective tissue of the sinus is not only populated by
stroma cells, passaging lymphocytes, and DCs that wander
through the sinus in search of danger; there is also a resident
population of rather immobile subcapsular macrophages that
settle between the retothelial cells. They constitute a big part of
the cell mass of the sinus. It is unknown if subcapsular
macrophages couple to the retothelial cells, if they bind to the
ECM within the sinus, and if there are specific signals that
localize these cells to the sinus. Interestingly, the subcapsular
macrophages are not 100% restricted to the sinus but also leak
into the first 10–30 mm of the cortex, which might support
their function as antigen relays (72). The morphological details
of the intermediate and medullary sinuses and the lymphatic
labyrinth are poorly described. As there is a continuum
between the subcapsular and the medullary sinus, the stroma
of both areas has strong similarities. Additionally, the
medullary sinus harbors antibody-secreting plasma cells.
The configuration of the sinuses is extremely flexible in
inflammatory situations. It has been shown that during the
course of a local LN activation by peripheral inflammation, the
sinuses enlarge within hours and become more extended and
also ‘infiltrate the cortex.’ This expansion has been interpreted
as a consequence of proliferating lymphatic endothelial cells
that invade the cortex and possibly make influx from the
periphery more effective (73). However, how closely the
retothelial cells indeed are related to the lymphatic lineage and
if they respond to the same growth factors as lymphatic
endothelia deserves further investigation. It is also possible
that the stroma cell population within the sinus is not
homogenous and that a population of lymphatic endothelial
cells exists in parallel to the retothelial cells (Fig. 3).
A remarkable but rarely mentioned characteristic of the sinus
is that it lacks blood vessels, and oxygenation has to be
provided by the underlying cortex (60). Teleologically, a lack
of blood vessels makes sense when viewing the sinus as the first
level of particle filtration with large pore sizes. A direct
connection to the blood circulation would bring along a high
risk of hematogenic distribution of infectious particles.
Consequently, all blood vessels in the LN are shielded from the
permeable sinus and are embedded into the filtrating conduit
system of the FRC network.
Solute transport within the sinus
Soluble molecules, particles, and cells periodically arrive with
the pumping contractions of the lymphatic vessels. At pressure
peaks, lymphatic fluid is actively pushed into the subcapsular
sinus. Although direct measurements are lacking, intravital
microscopy data suggest that fluid transport within the sinus
is rather unrestricted (2). The hydraulic radius of the sinus is
likely very large and allows not only soluble molecules but also
particles and cells to float through the meshwork of resident
cells. The solute distribution within the sinus can therefore be
described as percolation: the resident cells are bathed within
the unrestricted stream of afferent lymph. As the sinus system
allows open communication between subcapsular and medul-
lary areas, solutes can take a shortcut from afferent to efferent
lymph. This route is preferentially taken by immunologically
inert particles and larger molecules that are excluded from the
cortex, as they do not have access to the conduit system of the
T-cell cortex and further to the blood circulation.
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The requirement for such a ‘bypass route’ becomes especially
evident in the intestine, where the lymph does not only play a
role in fluid drainage and immune surveillance but also
transports the absorbed nutrients. Chylomicrons are collected in
the initial lymphatic vessel of the villus (the lacteal), are
channeled through the mesenteric nodes, and are transported
via the thoracic duct into the blood circulation. Immunologically,
all particles that pass through the sinus are irrelevant; they are not
visible for DCs, T, or B cells if they are not trapped in the sinus.
Selective trapping of solutes contained within the percolating
lymph is achieved by the resident cells of the sinus. Both
retothelial cells and macrophages catch soluble antigens and
efficiently endocytose particles and microbes (29, 74).
Accordingly, macrophages but also retothelial cells carry a rich
surface repertoire of scavenger receptors (C-type lectins and
many others) (65, 75) that unspecifically immobilize various
microbial antigens. How the retothelial cells contribute to
immune responses after antigen trapping is unclear, while it has
been recently shown that subcapsular macrophages can ‘hand
over’ antigen and even whole virus particles to B cells through the
floor of the subcapsular sinus (76–78). Junt et al. (77)
demonstrated the important concept that the filtering capacity of
subcapsular macrophages serves both innate and adaptive
immune functions. First, it is essential to mount effective B-cell
responses to viruses that arrive with the interstitial fluid. Second,
it prevents the hematogenic spreading of the virus itself. When
subcapsular macrophages were depleted from the sinus, virus
passed the LN without accessing the parenchyma and recirculated
via the efferent lymph and the thoracic duct into the blood
circulation (77).
It is a widely ignored fact that an access route for small
molecules into the sinus exists that is independent of afferent
lymphatics. The interstitium of the sinus is directly connected
to the ECM that constitutes the fibrous capsule of the node. The
capsule consists of fibroblasts, their fibrillar collagen matrix,
and likely many other components of a normal interstitium.
Although the capsule encases and mechanically protects the LN,
it does not shield it from interstitial fluids that surround the
node. It was shown that tracers injected close to the node
distribute along the capsular ECM and directly drain into the
sinus and most likely also further into the conduit system of the
T-cell cortex. This means that the ECM of the capsule forms a
fluid exchange continuum with the ECM of the sinus and the
parenchyma (79).
Cell movement within the sinus
Although histologically most areas of the sinus appear rather
densely packed with cells, intravital microscopy studies showed
that spacing of cells and interstitium is (at least in some areas of
the sinus) obviously loose enough to allow free floating of single
cells (2). Especially during pressure peaks caused by the peristal-
tic compressions of the afferent lymphatic pump, round cells are
flushed through the sinus. However, other intravital microscopic
studies also showed active amoeboid migration of DCs and T cells
within the sinus (80, 81). Hence, both active migration and
passive flowing occur in the sinus. Exit from the sinus has not
been studied intensively. One intravital microscopy study sug-
gested that the medullary sinus has preformed openings that
allow active exit from the medullary sinus into the efferent
lymphatics (82). Scanning electron microscopic studies favored
the lymphatic labyrinth that continuously connects to the
medullary sinus as the site of massive lymphocyte exit (59, 60).
It was shown by intravital microscopy that the sinus contains






Fig. 3. Particle movement within the sinus. The LN capsule consists of
interstitial matrix (blue) that is continued within the sinus. Here, the
matrix is surrounded by retothelial cells (green). Subcapsular macro-
phages (orange) are associated with the retothelial cells. Large particles
percolate through the sinus and become trapped on macrophages and
retothelial cells if they are immunologically relevant (triangles) and pass
into the efferent lymph if they are inert (round dots). Small molecules can
enter from the capsule and the sinus into the conduits of the T-cell cortex
from where they access the blood.
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retothelial cells and macrophages (80). It has not been addressed
if these DCs are representing a specialized subset or if they are
dermal DCs and Langerhans cells in steady state transit from the
periphery toward the T-cell cortex. Independent of their origin,
it is likely that these DCs are foraging for antigen and danger
signals that are immobilized on the retothelial cells or
macrophages. Once they detect a target, they likely go through
their usual program: they transiently arrest and phagocytose,
subsequently become motile, and actively enter the T-cell cortex
to present the antigen.
The sinus–cortex interface
The floor of the sinus is demarcated by a basement membrane
that has direct connections with the conduit system of the
cortex. However, this basement membrane is not continuous
and gaps allow cellular traffic without the need for proteolytic
degradation. The stroma cell that is directly covering the floor
of the sinus has been termed, describing its position, the sinus-
lining cell. It has not been addressed if this cell is a morpho-
logical variant of the retothelial cell, a form of lymphatic
endothelial cell, or a separate specialized cell lineage.
Penetration of fluid and small molecules into
the parenchyma
Almost 50 years ago, tracer experiments demonstrated that
there is no free exchange of small molecules between the sinus
and the T-cell parenchyma (70). Although not widely acknowl-
edged in textbooks, these findings clearly argued against free
percolation being the principle of interstitial flux in the T-cell
area. In their seminal tracer studies, the laboratories of
Anderson and Shaw (58, 83) showed that rather than percolat-
ing through the parenchyma, small molecules are channeled
through the conduit system of the T-cell area. Interestingly,
molecules with a molecular weight above the size of albumin
(70 kDa) were excluded from the parenchyma and were
exclusively detectable within the sinus (58). Most large mole-
cules and particles eventually exit the node via the efferent
lymphatic vessel, without ever becoming immunologically
visible. The fraction of large molecules that is not bypassing
the T zone is trapped by retothelial cells or sinus macrophages
and further processed.
The communication between the sinuses and the T-cell
cortex is restricted for large soluble molecules and bigger
particles. Small molecules can enter the cortex but remain
confined to the conduit system instead of percolating between
the T cells. The morphological correlate of the size-selective
sinus-cortex barrier is not known. Below we put forward the
idea that a physical barrier is not required to explain the
exclusion of soluble molecules from the T-cell parenchyma
but that this is just a consequence of a lacking interstitium
between T cells.
Passage of cells through the sinus floor
Restricted movement of soluble molecules suggests that also
cellular trafficking between sinus and cortex is restricted.
However, this does not seem to be the case. It has been shown
by intravital microscopy that T cells can effortlessly glide into
the subcapsular sinus when exposed to artificial gradients of
chemokine (81). Observations of DCs penetrating the subcap-
sular sinus suggested the same: locomotion kinetics of cells at
the sinus cortex interface did not indicate that a barrier has to
be traversed (84). If the sinus lining cells are discontinuous, if
they ‘open the gate’ on demand, or if they are traversed
transcellularly is unknown. Taken together, active cellular
movement between sinus and cortex is possible while the
passive movement of solutes and particles is restricted. Mole-
cules, be it foreign antigens or endogenous factors dissolved
in the interstitial fluid, with a size below 70 kDa can enter the
T-cell cortex via the conduit. Larger molecules are excluded and
have to enter as cellular cargo on the surface or inside incoming
DCs or are relayed into the B-cell follicle by macrophages.
The T-cell cortex
The stromal backbone
The anatomy of the T-cell cortex is dominated by the densely
packed T cells that constitute more than 95% of the cellular
mass. The remaining space is occupied by resident DCs and the
T-cell stroma cells. The stroma is the infrastructure that dictates
shape and organization of the T zone. It is the only stable
component while T cells are in continuous motion to maintain
the high contact frequencies with DCs. The T-cell stroma is
condensed to a minimal volume and has an extremely unusual
appearance. It forms a filigrane three-dimensional network that
is highly interconnected via cell–cell contacts and structurally
resembles the skeleton of a sponge (67). The cells forming this
network are called FRCs, and the ECM they assemble has been
termed conduit, after its function to channel small molecules
through the cortex. The stromal endoskeleton of the LN is
therefore not only a structural backbone but also a complex
system of tubes that forms one continuously interconnected
fluid exchange system with physical connections to all sinuses
and all blood vessels.
The conduit
The conduit, varying in diameter from 200 nm to 3 mm,
contains all known types of ECM molecules from peripheral
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tissues, with the decisive distinction that they are assembled in
a highly ordered manner. The center of the conduit is formed
by parallel bundles of fibrillar collagens (I, III). Associated with
these bundles, depending on the size of the conduit, are the
typical collagen-associated stabilizing and crosslinking molecules
like fibromodulin, decorin, and lumican (our unpublished data).
The collagen fibers vary in number from 20 to 200 per cross-
section, and the individual thickness varies around 50 nm (57,
85). They are not tightly packed. Transmission electron micro-
scopy studies demonstrated that an unordered meshwork of
5–10 nm fibrils, morphologically resembling microfibrils, fills
the space between the collagen fibers (86). The whole array of
collagen bundles is embedded in a coat of microfibrils. Accord-
ingly fibrillins, the molecular constituents of microfibrils have
been detected between and especially around the collagen fibers
(29). Although not been thoroughly investigated, it is most
likely that, as in the interstitium of the periphery, glycosamino-
glycans are filling the gaps between fibers and fibrils. In human
LNs, dermatan sulfate was detected in association with the
conduit ECM, but studies of other sugars are missing (87). The
fibrillar core is a cell-free compartment that is tightly enclosed by
a basement membrane that forms a cylindrical cover, giving the
conduit the ultrastructural appearance of a tube. The cell that
produces and settles on the basement membrane is the FRC. It
forms a cellular sleeve around the conduit by anchoring to the
basement membrane. The FRC continuously enwraps the con-
duit, and by forming intracellular cell–cell contacts, they seal the
conduit against the T-cell-containing parenchyma. Along the
longitudinal axis, the individual FRCs connect with intercellular
junctions (57). The exact nature of the cell–cell junctions
between the FRCs remains to be determined. Although more
than 95% of the conduit is covered with FRCs, gaps remain that
are covered by hematopoietic cells (29, 88, 89). These cells are
mainly resident DCs that are embedded in the FRC layer and
extend processes into the lumen of the conduit.
The conduit as a compacted interstitium
The conduit structure by itself appears rather unusual, as
basement membranes normally form two-dimensional sheets
that separate mesenchymal from epithelial compartments.
However, when envisaging the conduit core as a very con-
densed form of a conventional interstitium, the whole arrange-
ment appears more familiar and could be viewed as a
compacted and tiny version of the peripheral interstitium that
we described for the dermis. It is compacted to an extent that it
appears as a system of microchannels that are bordered by a
basement membrane. To appreciate the similarity between
peripheral interstitium, we suggest the following thought
experiment: imagine a vascularized mesenchymal tissue and
extend the luminal surface of the endothelium until the
interstitium almost disappears. The curvature of the endothelial
lumen eventually bends backwards, and the interendothelial
junctions reconnect without changing endothelial polarity. The
endothelial cells would now ‘internalize’ their own intersti-
tium, and by wrapping around the ECM, they will seal it against
the ‘luminal’ surface that is in contact with the hematopoietic
cells. Such a tissue would now resemble the T-cell cortex,
where the blood cells occupy the labyrinthine ‘lumen’ formed
by the FRCs, and the extravasacular space would be too tiny to
contain any cells. In such a view, the T-cell cortex would rather
be a specialized intravascular compartment than an extravascu-
lar space. In the T-cell cortex, FRCs take the function of both
interstitial fibroblasts and endothelial (or epithelial) cells. FRCs
clearly display features of epithelial and endothelial cells (apical
basal polarity, cell–cell junctions, an underlying basement
membrane, expression of cytokeratins) but also have character-
istics of a fibroblast with myofibroblastic features (production
of interstitial matrix, smooth muscle actin, expression of
desmin and vimentin) (57, 90, 91).
LN anatomy during development and inflammation
The FRC network is an extreme variant of stromal differentia-
tion that is already emerging in the sinus where a certain but
not as extensive condensation of stroma and ECM occurs. This
morphological continuity becomes obvious when looking at
large collagen bundles that branch off the fibrous capsule, cross
the subcapsular sinus (here they are loosely decorated with
basement membrane patches and covered with retothelial
cells), and enter the T-cell parenchyma, where they become
incorporated into the conduit network. The view of a con-
densed interstitium is also consistent with the ontogeny of the
FRC. During developmental and inflammatory lymphorgano-
genesis, FRCs are described as ‘organizer cells’ that are differ-
entiating in a mutual crosstalk with hematopoietic ‘inducer
cells’ that provide lymphotoxin signals. These lymphotoxin
signals drive the transformation process of undifferentiated
scattered mesenchymal cells into the FRC lineage (92, 93). The
origin of undifferentiated mesenchyme in adult tissues is
unclear, but the pericyte pool might be an interesting source.
The FRC differentiation, which goes along with the formation
of cell–cell junctions and polarization, resembles mesenchymal
condensations or mesenchymal epithelial transitions that are
well described in many other organogenetic processes like
bone formation or kidney development (94).
In terms of anatomical features, the T-cell area is rather
homogenous and does not show qualitatively distinct regions.
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A quantitatively distinguishable area has been termed ‘cortical
ridge.’ This is the T-cell area in close vicinity to the B-cell
follicles. The cortical ridge shows a high density of high
endothelial venules, and also the spacing of the reticular fibers
was described as more densely packed (95).
The T-cell area shows enormous plasticity. During acute
inflammation, LNs massively expand within hours, and the
number of lymphocytes in the node multiplies. Theoretically,
the sponge-like architecture of the T-zone stroma would allow for
a certain swelling without increasing the surface area of the FRC
network that could at the same time maintain structural integrity.
However, mechanical expansion does not seem to be the critical
factor, as it has been shown that during LN swelling the FRC
surface expands. Although quantitative data on FRC spacing
during LN expansion are lacking, qualitative data indicate that
the FRC network grows with the increasing number of
lymphocytes (96). It will be interesting to find out which
factors keep the FRC to T-cell ratio constant. One possibility is
that such a homeostatic balance might be regulated by factors that
also regulate organogenesis like lymphotoxins.
Solute transport within the T-cell zone: entry into
the conduit system
While in the periphery and in the sinus interstitial fluid and
particles percolate around the cells through the interstitial
space, the situation is radically different within the T zone.
Large molecules are completely excluded from the parenchy-
ma; they remain restricted to the sinus. Small molecules cannot
be detected between the T cells either, but they have access to
the conduit core. After subcutaneous injection, small molecular
weight tracer molecules exclusively locate within the conduits,
where they are sheltered from the T cells by the conduit
basement membrane and the FRC layer around it (29, 57,
87). The conduit system is not a blind ending network but is
highly connected with the capillaries and venules of the cortex
(67). The conduits drain their fluid into the bloodstream:
subcutaneously injected small molecules appear within the
lumen of the high endothelial venules within minutes, demon-
strating a shortcut between lymphatic fluid and blood at the
level of the first draining LN (58, 83).
What is the physiological mechanism behind this size
selective and directed transport? It has been proposed that
flow within the conduit is active, meaning that sinus-lining
cells at the sinus cortex interface (where the conduits start)
pump the interstitial fluid into the conduits in a size-selective
manner. Gretz et al. (57) suggested that a high transcytotic
activity of the sinus-lining cells might support this function.
However, it is entirely unclear how the conduit system could
actively maintain pressure gradients that promote directed
movement of fluid through such a complex and highly
interconnected meshwork. A theory of active transport would
also require an active exclusion mechanism that prevents entry
of solutes into the T zone and a resulting percolation between
the T cells. A recently published study showed that a small
molecular tracer quickly distributed from the subcapsular sinus
into the B-cell follicles, where it located diffusely between the
lymphocytes. Interestingly, within the T zone the tracer
distribution was restricted to the conduits (97). As there is
clearly no anatomical barrier between T and B zone, such
observations are difficult to include in a theory of active fluid
transport through the conduits.
We propose that solute distribution within the T zone is
a simple consequence of the biophysical characteristics of the
T-zone interstitium. Instead of postulating that solutes are
actively pushed into and confined within the conduit
compartment, we propose that the conduit is the only space
where interstitial fluid can distribute for reasons of hydraulic
conductivity. As mentioned above, the FRCs are highly
polarized, and on their apical side, they do not display or bind
any ECM molecules (29). As T cells or DCs do not produce their
own ECM, the T-cell compartment does not contain any
interstitium that fills the intercellular space. This is a highly
unusual situation and means that T cells are shielded from any
ECM environment. Even the ‘fluid phase ECM’ of the blood, the
serum proteins, are absent as the interstitial fluid is exclusively
channeled through the conduit. This is indicated by tracer
experiments where soluble molecules below 10 kDa were not
visible between the T cells but restricted to the conduit (58).
Hence, T cells move within a ‘vacuum’ and are packed at
maximal density (98). As such, the T-cell compartment
resembles a cell pellet after centrifugation. It is likely that the
hematopoietic cells in the T zone are so tightly packed that they
almost slide along each other in a membrane to membrane
fashion, just separated by a layer of transmembrane proteins
and cell surface glycosaminoglycans (that remain to be
characterized in detail).
Although direct measurements of the hydraulic conductivity
within the T-cell area are missing, it is likely that both diffusion
and convection are extremely low between the T cells and that
all significant fluid movements happen in the porous
environment of the conduit core. Such a ‘passive’ view of the
conduit system also explains that tracers continuously disperse
from the LN capsule through the sinus into the conduit system.
The continuity of the interstitial matrix allows for a free
distribution within the interstitium, driven by Starling’s forces
that define the direction of flow.
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The simple model of the conduit as a compact version of the
dermal interstitium that is following the same physiological
rules also implies that the B-cell area is behaving fundamentally
differently, as it allows the free distribution of small soluble
molecules. In this context, it is interesting that B-cell follicles
show a diffuse staining for hyaluronic acid (our unpublished
data) and are positive for the ECM molecule vitronectin (99).
These findings open the possibility that B cells are surrounded
by an interstitium with larger hydraulic conductivity than the
T cells.
The driving force of solute distribution in the
conduit system
In most peripheral tissues, the capillary system is in a state of
continuous filtration, while the lymphatics absorb the filtered
fluid volume. The situation changes in tissues where fluid
enters via a separate route and creates a fluid excess. This is the
case for submucosal tissues, where fluid enters across the gut
epithelium, and for LNs, where interstitial fluid enters via the
sinus (19). In gut and LN, Starling’s forces result in an
interstitial flux toward efferent capillaries and venules and
cause a flow of fluid and small molecules into the blood
system. Hence, LNs are in a continuous state of fluid absorp-
tion, which is reflected by measurements that show that the
protein content of the afferent lymph is far below that of the
efferent lymph (100–104). It is likely that absorption in the LN
is as important for maintaining peripheral fluid homeostasis as
the recirculation of interstitial fluid via the thoracic duct.
Unfortunately, comparative measurements of the molecular
weight distribution of proteins within afferent and efferent
lymph are lacking. Such data would allow to quantitatively test
the 70 kDa size exclusion volume of the conduit. They might
be further of pharmacological importance, as the lymph-blood
shortcut at the level of the draining LN might be an important
route for how subcutaneously applied substances enter the
blood circulation. To understand the interstitial flow within the
conduit, we further require a more detailed view of its
molecular composition and biophysical properties. The extent
to which sugars carrying fixed charges are embedded within
the core region and the basement membrane will be required
to estimate its swelling force and the hydraulic conductivity.
It will be interesting also to test the conduit function during
altered physiological states like in the absence of afferent lymph
drainage and elevated venous pressure. Under homeostatic
conditions, the conduit system does not fill via the blood
system, but this might change upon alterations of hydrostatic
conditions. It has been shown that artificially increasing the
venous pressure not only leads to a higher peripheral filtration
rate of plasma but also causes dilution of the efferent lymph.
This steeper decrease in protein content of the afferent versus
the efferent lymph was due to decreased fluid absorption in the
draining LN (100). High venous pressures might even lead to
retrograde filling of the conduits via the blood. Studying the
fluid balance of LNs in detail would tell us if the conduit system
does indeed follow the rules of Starling or if active transport
mechanisms, like water transport via aquaporin channels that
are expressed in sinus-lining cells and LN endothelium (60),
play a role.
When reflecting the physiology of fluid transport in LNs, it
is interesting that the conduits of the spleen (105) and the
thymic medulla (our unpublished data) fill via the blood
system. In both cases, the conduits are solely connected to the
blood vessels and the organs have no additional supply via
lymphatics. Hence, these tissues should be in a state of
continuous apillary filtration which matches the direction of
interstitial flux within their conduits.
Small molecules and fluid are channeled through the conduit
system of the T-cell cortex and drain into the vasculature. If
access into the T-cell area is completely restricted and no solutes
leak into the parenchyma, then where does the filtration take
place and which sense does it make to channel all liquid
through the T-cell cortex? It was demonstrated that the cell
type that has best access to the content of the conduit is the
resident DC that extends processes through the FRC layer into
the lumen of the conduit (29, 30, 88, 106). Via this route, DCs
can sample the content of the interstitial fluid like any other DC
in the periphery can. Soluble antigens can be acquired and
presented but also extracellular signaling molecules produced
in the periphery can potentially be sensed. Via the conduit, the
resident DCs of the LNs are rapidly informed about the state of
the periphery. In other words, the soluble periphery is
continuously projected into the conduits, and resident DCs
can read out its condition. Immunologically, this principle is
most effective, as the only cell that has to collect environmental
information is the DC. T cells are not involved in ‘decision
making’; they just receive instructions from the DC (7). The
anatomy of the T zone guaranties that they are not exposed to
information they never need.
Functional implications of the conduit system
Even more enigmatic than these proximate aspects of conduit
mechanisms is the ultimate question concerning the adaptive
value of excluding large molecules from the conduit. We
propose that size exclusion is a universal and efficient way to
prevent that the lymph–blood shunt within the draining node
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is exploited by infectious agents. By depleting subcapsular
macrophages, Junt et al. (77) demonstrated that the filtering
function of the sinus is essential for preventing the spread of
virus particles via the blood circulation. In the absence of the
scavenger function of the macrophages, virus arriving with the
interstitial fluid quickly distributed via the thoracic duct into
the blood and became systemic (77). Especially in bigger
animals (and humans), many LNs are connected ‘in row’
(17), and it is likely that if virus is not cleared in the first node
it becomes trapped in one of the following. If the conduits
would not filter out large particles that have the potential to
replicate, the lymph–blood shortcut would support hemato-
genic distribution and therefore would be a fatal distribution
system for pathogens. In other words: as the LN blood vessels
absorb fluid, a LN interstitium without a size exclusion volume
would compromise the entire filtering concept of the LN.
We think that a larger exclusion size of the conduit would be
dangerous for the organism. But what would be the
consequence if the FRC network were to lack an interstitium,
if the conduits would not exist? Why are they useful? The
experiment to genetically eliminate the FRC interstitium has
not been done, so we have to rely on indirect evidence.
Immunologically, there seem to be two main functions of
conduits: distribution of soluble antigens and endogenous
signaling molecules toward resident DCs and information
relay from the periphery into the lumen of high endothelial
venules. In the absence of conduits, resident DCs would most
likely have no access to soluble antigens or cytokines produced
in the periphery – all the information would need to be
(slowly) carried in by infiltrating DCs. Although this sounds
like a dramatic change, it is far from clear what role soluble
molecules have for the course of T-cell immune responses.
Itano et al. (106) showed that soluble antigen presented on
resident DCs can elicit T-cell responses. However, these
responses were not sustained, and it is possible that they
rather act as initiators that have to be consolidated by later
incoming DCs. The only infectious model where immunity has
been shown to be mainly triggered by soluble antigen is
leishmaniasis (107). It remains to be shown how general such
processes are and if soluble antigens are as important for the
triggering of T-cell responses as they are for humoral
immunity. Current data suggested that for tolerance induction,
soluble antigens are not decisive, as maintaining tolerance is
completely dependent on CCR7-mediated steady state
migration of DCs (108). Much work has to be done on the
role of soluble antigen.
The conduits as an information distribution system for
resident DCs have not been addressed directly, and it would be
interesting to see how resident DCs react to soluble cytokines
or chemokines that arrive with the afferent lymph. Conduits as
information superhighways have been studied in another
context. It was demonstrated that chemokines produced in the
periphery are rapidly (within seconds) channeled with the
interstitial flux via the conduits into the lumen of high
endothelial venules (109, 110). Here, they became
immobilized to the luminal side of the endothelium, were
sensed by circulating lymphocytes, and modulated their entry
into the parenchyma. This system was interpreted as a remote
control of the LN by the peripheral tissue and completes the
picture of the LN as an immunological projection of the
periphery that can rapidly adapt to peripheral threats (110).
A completely neglected context in which conduits might
play a decisive role is fluid homeostasis. The fact that high
amounts of fluids are resorbed into the blood circulation
within the draining LN suggests that in the absence of
conduits, interstitial fluid would either recirculate entirely via
the efferent lymph and the thoracic duct or peripheral edema
would develop. Unfortunately, data on the thoracic duct
transport volume and the hydration state of peripheral tissues
in mice lacking LNs for genetic reasons are not available.
Cell migration within the T-cell cortex
The functions of the FRC network are not entirely connected
with the formation of conduits. As the only non-hematopoietic
cells of the T-cell cortex, the FRCs are also organizing the
migratory patterns of the blood cells. Cell migration patterns
within the T-cell cortex were subjects of intense investigation
during the last years, and many excellent reviews on this topic
are available (9, 11–13). Here, we focus on the direct role of
the stromal network for T-cell and DC migration. Although
Gretz et al. (57) predicted that the FRC network plays a decisive
role in guiding T cells through the LN, the reticular network
was long ignored by intravital microscopists studying the
swarming of T cells. The pathway taken by T cells was
described as a random walk, and the encounters with DCs were
regarded as random collisions (11, 57, 111). Bajenoff et al.
(112) demonstrated that the opposite is the case: they showed
that the routes of T-cell migration are not at all random but
rather deterministic, as they lead preferentially along the FRC
network. A theoretical model that tried to match experimental
data on T-cell movement came to the same conclusion (113).
By simultaneously visualizing T cells and FRCs in vivo, Bajenoff
et al. (112) showed that the migration tracks of most T cells
were aligned with the FRC scaffold. The migration direction of
the T cells on the tracks was random. Hence, the FRCs appear to
be an adhesive and chemokinetic surface that lack intrinsic
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directional information (112, 114). FRCs are the producers of
the homeostatic chemokines CCL19 and CCL21 that bind to the
chemokine receptor CCR7 that is expressed on naive T cells
(54, 115, 116). Both chemokines trigger and maintain the
motile state of T cells and are essential for their swarming
behavior. As CCL21 immobilizes to the FRC network, it is
possible that the FRC network forms a chemokinetic surface
that keeps the T cells dynamic and at the same time restricts
their migration to the T-cell area. Such a system of chemoki-
netic surfaces has the attractive potential to generate high
migration dynamics within sharp boundaries. In an indepen-
dent study, the Germain laboratory (117) proved another
important principle: cytotoxic T cells are able to respond
quickly and flexibly to chemokines that are locally released by
a successfully interacting pair of DC and helper T cell. Single
cell tracking in vivo revealed that cytotoxic T cells actively
chemotax toward the signal source (117). This finding means
that the chemokinetic principle of swarming can be locally
overcome by gradients that steer cells in a certain direction. If
this directional migration is still guided along the FRC network
or if T cells become autonomous from the chemokinetic
scaffold once they follow soluble gradients is unknown. Many
issues have to be resolved until a cell biological model of
migration within the cortex will be available. Determining the
role of soluble versus immobilized chemokines is one, while
the question how T cells adhere to the FRC surface is another. It
is also unclear how FRCs exactly handle the chemokines they
produce. Interestingly, most of the CCL21 in the LN associates
with the basement membrane of the conduit, where it likely
immobilizes to the heparan sulfate residues (our unpublished
data). Can the FRCs actively shuttle chemokine onto their apical
surface where the T cells can sense it, and could such a step be
flexibly regulated?
It is likely that DC migration within the cortex follows in
principle similar rules: the population of resident DCs is
partially embedded into the FRC layer, and it was shown also
that antigen-carrying DCs immigrating from the periphery
become incorporated into these networks (80). Like naive
T cells, immigrating DCs respond primarily to CCR7 ligands
(31). How the resident DCs couple to the FRC network is
unknown, but it is most likely that they use cell surface
receptors to interact with conduit and FRCs. One study
showed that the DC population most tightly associated with
conduits expresses high levels of a collagen-binding integrin
(118). Importantly, migration along the FRC tracks leads the
T cells directly into the DC networks and is therefore an ideal
strategy to maximize encounters. However, testing the importance
of these optimization strategies will require immunological
methods that challenge the detection limit of the adaptive
immune system. Most of the common manipulations work with
high doses of antigen and high frequencies of (transgenic) T cells
that easily find each other, even in the absence of sophisticated
guidance systems.
The functional unit of the T zone
We reviewed the anatomical and physiological features of a LN
that define its function as a filter for soluble molecules and as an
organizer of cellular encounters. We described in detail how
the conduit, its FRC sleeve, the DCs embedded between the
FRCs and the T cells gliding along the FRC surface form the






Fig. 4. Functional unit of the T-cell cortex. Upper schematic: the T-cell
cortex is packed with T cells (gray) and dendritic cells (orange) and is
interspersed with FRCs (green) that contain interstitial matrix in their
lumen and connect with the blood vessels (red). Lower schematic: FRCs
enwrap the conduit that consists of interstitial matrix and a surrounding
basement membrane (brown). DCs associate with the FRCs and extend
processes into the conduit lumen that can take up small molecules that are
flushed through the conduit toward the blood vessels. T cells move on the
surface of the FRCs and collide with the DCs.
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essential environment that supports the principle of the
adaptive immune system, where rare cell–cell encounters have
to be selected. Accordingly, the functional unit characterizes
not only all secondary lymphatic organs but it forms almost
everywhere in the sustained presence of lymphocytes. Likely
driven by cell surface lymphotoxin, the mesenchymal conden-
sation is triggered that ultimately leads to the assembly of
conduits, FRC networks, embedded DCs, and swarming T cells
that are searching their cognate antigen. Accordingly, conduit-
like structures are not only found in secondary but also in
tertiary lymphatic organs and even in chronically inflamed
areas like the perivascular space and the parenchyma of brains
of multiple sclerosis patients (119, 120) (Fig. 4).
Conclusion
Although LNs gained much attention during the last years of
intense dynamic imaging, they are still frequently viewed as
simple containers for swarming and interacting blood cells.
However, they are much more, and it is beyond doubt that the
LN’s complex stromal infrastructure is absolutely essential for
organizing the dynamic state of order required for the high
encounter rates between innate and adaptive immune cells. We
are still far away from an integrated physiological concept of
lymph nodes as the filter stations of the interstitium. It will be
necessary to collect basic physiological data on LN fluid home-
ostasis under normal and inflammatory conditions and inte-
grate them into the concept of adaptive immune priming.
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